CDSCO mandates SUGAM portal for vaccine and anti-sera post-approval-change submissions from 1 July 2026
Vaccine and anti-sera applicants must submit post-approval-change applications for Registration Certificates and Import Licences via the SUGAM portal; hard-copy and email submissions are refused from 1 July 2026
- — Regulatory affairs teams at human vaccine and anti-sera Registration Certificate and Import Licence holders must file all Post Approval Changes applications through the SUGAM portal's other-section checklist module from 1 July 2026 — applications submitted in hard copy through the CRU or by email will not be accepted for processing from that date.
- — Regulatory affairs teams must migrate any in-progress or planned post-approval-change submissions to SUGAM before 1 July 2026 — relying on the CRU or email route after the cut-off leaves the application unprocessed.
- — Regulatory affairs teams at human vaccine and anti-sera Registration Certificate holders
- — Regulatory affairs teams at human vaccine and anti-sera Import Licence holders
- — 1 July 2026: CDSCO stops accepting hard-copy (CRU) and email submissions of vaccine and anti-sera post-approval-change applications; SUGAM becomes the only accepted channel.